Ignite Creation Date:
2024-05-06 @ 3:07 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04521153
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2021-04-27
First Post:
2020-08-18
Brief Title:
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Shanghai Zhongshan Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-18
First Submit QC Date:
August 19 2020
Study First Post Date:
2020-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2021-04-27
Last Update Post Date Type:
ACTUAL